While Semaglutide is generally considered safe for long-term use, its essential to discuss potential risks and benefits with your healthcare provider, especially if you have pre-existing medical conditions
The study was funded by the National Institutes of Health (grants R01DK125260, P30DK116074, K99AR081618 and GM113854), the SPARK Translational Research Program at Stanford, Stanford Bio-X, the Stanford Maternal and Child Health Research Institute, the American Heart Association, a Stanford Medicine Deans Fellowship Award, the Carlsberg Foundation, and the Wu Tsai Human Performance Alliance
If you follow the standard titration, one 10 mg vial provides: Phase 1 (weeks 1 to 4 at 0.25 mg): uses 1 mg Phase 2 (weeks 5 to 8 at 0.5 mg): uses 2 mg Phase 3 (weeks 9 to 12 at 1.0 mg): uses 4 mg Total through 12 weeks: 7 mg used, 3 mg remaining Remaining 3 mg covers about 1.5 to 2 more weeks at 1.7 mg One vial
Wegovy comes as a pre-filled injector pen